Limited time75% off all plans
Get the app

IVIG resistance

On this page

Definition & Risk Scores - The Unyielding Fever

  • IVIG Resistance: Defined as persistent or recrudescent fever (≥38°C) lasting for ≥36 hours after the completion of the initial IVIG infusion. This affects up to 20% of Kawasaki disease patients.

  • Key Laboratory Predictors for Resistance:

    • ↑ C-reactive protein (CRP) >8 mg/dL
    • ↑ Neutrophil count >80%
    • ↓ Serum albumin <3.5 g/dL
    • ↓ Sodium <135 mEq/L
    • ↑ Alanine transaminase (ALT)
  • Clinical Risk Scoring Systems:

ParameterKobayashi Score (≥5 pts)Egami Score (≥3 pts)
Age12 months (1 pt)6 months (1 pt)
Sodium133 mEq/L (2 pts)-
AST100 IU/L (2 pts)-
Platelets30.0 x10⁴/μL (1 pt)-
CRP10 mg/dL (1 pt)8 mg/dL (1 pt)
Neutrophils80% (2 pts)-
Albumin-3.5 g/dL (1 pt)

Treatment Algorithm - Plan B Protocols

Management of patients who remain febrile ≥ 36 hours after the initial IVIG infusion.

⭐ Patients with IVIG-resistant Kawasaki disease have a significantly higher risk (up to 25%) of developing coronary artery aneurysms compared to responders.

Complications & Monitoring - The Artery Attack

IVIG resistance significantly ↑ risk of Coronary Artery Aneurysms (CAA), the hallmark complication.

  • Risk Profile:
    • Untreated: ~25% develop CAA.
    • IVIG-Treated: Risk ↓ to <5%.
    • IVIG-Resistant: Risk is substantially higher, mandating aggressive follow-up.
  • Monitoring:
    • Intensified surveillance with serial echocardiography is crucial to track coronary artery dimensions and function.
  • Other Complications:
    • Myocarditis
    • Macrophage Activation Syndrome (MAS)

⭐ Most coronary artery changes develop within the first 4 weeks after fever onset. Early detection is key.

Echocardiogram of giant coronary artery aneurysms in KD

High‑Yield Points - ⚡ Biggest Takeaways

  • IVIG resistance is defined as persistent or recrudescent fever ≥36 hours after completing the initial IVIG infusion.
  • It is the strongest predictor for the development of coronary artery aneurysms (CAA).
  • High-risk patients can be identified by scoring systems like the Kobayashi score.
  • The standard second-line treatment is another dose of IVIG (2 g/kg).
  • For refractory cases, treatment options include corticosteroids (prednisolone) or infliximab.

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE